{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:23:17Z","timestamp":1787768597378,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that can occur as an idiopathic condition or in association with various systemic diseases. The association with Sj\u00f6gren\u2019s syndrome (SS) is extremely rare, with only a few cases reported in the literature where PG developed in patients with established SS. We report the unique case of a 39-year-old female who presented with painful hemorrhagic bullae affecting the lower extremities, upper lip, and back, which rapidly evolved from nonpruritic papules. The patient also complained of arthralgia in small joints of both hands and had a history of dry mouth and eyes. Laboratory investigations revealed elevated inflammatory markers, positive antinuclear antibodies, and strongly positive anti-SSA\/Ro and anti-SSB\/La antibodies. Histopathological examination confirmed neutrophilic dermatosis compatible with PG. Schirmer\u2019s test was markedly positive, and salivary gland biopsy showed minimal inflammation, confirming the diagnosis of SS according to established classification criteria. The patient was initially treated with high-dose intravenous methylprednisolone and colchicine with good initial response. The patient showed excellent response with significant improvement in skin lesions and control of SS symptoms at a 3-month follow-up. This case highlights the importance of screening for underlying autoimmune connective tissue diseases in patients presenting with neutrophilic dermatoses.<\/jats:p>","DOI":"10.4103\/aam.aam_262_25","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:00:41Z","timestamp":1757955641000},"page":"969-973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Manifestations of Primary Sj\u00f6gren\u2019s Syndrome: Pyoderma Gangrenosum as a Rare Initial Presentation \u2013 A Case Report and Literature Review"],"prefix":"10.4103","volume":"25","author":[{"given":"Ajinkya","family":"Devadkar","sequence":"first","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhangi","family":"Kanitkar","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12016-017-8639-y","article-title":"Cutaneous and mucosal manifestations of Sj\u00f6gren's syndrome","volume":"53","author":"Generali","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2018.03.002","article-title":"Update on Sj\u00f6gren syndrome and other causes of sicca in older adults","volume":"44","author":"Baer","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/jpm13060961","article-title":"The spectrum of extraglandular manifestations in primary Sj\u00f6gren's syndrome","volume":"13","author":"Mihai","year":"2023","journal-title":"J Pers Med"},{"key":"R5-20260803","first-page":"632","article-title":"Cutaneous manifestations of primary Sj\u00f6gren's syndrome are underestimated","volume":"22","author":"Roguedas","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R6-20260803","first-page":"55","article-title":"Sj\u00f6gren's syndrome: A retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology","volume":"22","author":"Bernacchi","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s10067-006-0374-3","article-title":"Cutaneous findings in patients with primary Sjogren's syndrome","volume":"26","author":"Soy","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-017-8621-8","article-title":"A comprehensive review of neutrophilic diseases","volume":"54","author":"Marzano","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.qjmed.a067865","article-title":"Pyoderma gangrenosum: A review of 86 patients","volume":"55","author":"Powell","year":"1985","journal-title":"Q J Med"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: A retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R11-20260803","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00281-015-0549-6","article-title":"Neutrophilic dermatoses and autoinflammatory diseases with skin involvement \u2013Innate immune disorders","volume":"38","author":"Navarini","year":"2016","journal-title":"Semin Immunopathol"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10354-014-0285-x","article-title":"Pyoderma gangrenosum: Pathogenetic oriented treatment approaches","volume":"164","author":"Wollina","year":"2014","journal-title":"Wien Med Wochenschr"},{"key":"R13-20260803","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: A retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4049\/jimmunol.1800760","article-title":"Cutting edge: Dysregulated CARD9 signaling in neutrophils drives inflammation in a mouse model of neutrophilic dermatoses","volume":"201","author":"Tartey","year":"2018","journal-title":"J Immunol"},{"key":"R16-20260803","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/acr.22974","article-title":"Severe health-related quality of life impairment in active primary Sj\u00f6gren's syndrome and patient-reported outcomes: Data from a large therapeutic trial","volume":"69","author":"Cornec","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R17-20260803","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R18-20260803","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren's syndrome: A retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"ter Borg","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R19-20260803","first-page":"185","article-title":"Prevalence of extraglandular manifestations in patients with primary Sj\u00f6gren's syndrome in Southern Norway: A comparison to the literature","volume":"30","author":"Jorkjend","year":"2015","journal-title":"Arch Rheumatol"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000446780","article-title":"Abberant sudomotor functions in sj\u00f6gren's syndrome: comparable study with atopic dermatitis on dry skin manifestation","volume":"51","author":"Katayama","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"R21-20260803","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren's syndrome: New clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R22-20260803","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary Sj\u00f6gren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"Garc\u00eda-Carrasco","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R23-20260803","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coms.2013.09.008","article-title":"Extraglandular manifestations of primary Sj\u00f6gren's syndrome","volume":"26","author":"Ienopoli","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R24-20260803","first-page":"25","article-title":"Extraglandular cutaneous manifestations in patients with primary Sj\u00f6gren's syndrome","volume":"25","author":"Ramos-Cervera","year":"2018","journal-title":"Rev Colomb Reumatol Engl Ed"},{"key":"R25-20260803","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/art.1780281205","article-title":"Peripheral inflammatory vascular disease in Sj\u00f6gren's syndrome. Association with nervous system complications","volume":"28","author":"Molina","year":"1985","journal-title":"Arthritis Rheum"},{"key":"R26-20260803","first-page":"237","article-title":"Cardiovascular risk factors and the long-term outcome of primary Sj\u00f6gren's syndrome patients","volume":"99","author":"Font","year":"2006","journal-title":"QJM"},{"key":"R27-20260803","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1684\/ejd.2009.0685","article-title":"Pyoderma gangrenosum associated with Sj\u00f6gren syndrome","volume":"19","author":"Ravic-Nikolic","year":"2009","journal-title":"Eur J Dermatol"},{"key":"R28-20260803","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.kjms.2013.11.005","article-title":"Pyoderma gangrenosum: Intractable leg ulcers in Sjogren's syndrome","volume":"30","author":"Tsai","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"key":"R29-20260803","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-203445","article-title":"When an ulcer is not 'just an ulcer': Pyoderma gangrenosum","author":"Anderson","year":"2014","journal-title":"BMJ Case Rep 2014"},{"key":"R30-20260803","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: Results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"R31-20260803","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/1756-185X.13086","article-title":"Pyoderma gangrenosum in Sj\u00f6gren's syndrome and its successful treatment with topical application of etanercept","volume":"20","author":"Haridas","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R32-20260803","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.det.2023.12.002","article-title":"Treatment of pyoderma gangrenosum","volume":"42","author":"Tan","year":"2024","journal-title":"Dermatol Clin"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_262_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:16:42Z","timestamp":1787768202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_262_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_262_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"2025-06-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}